Teresa D. Melo-Pinho

Coimbra, 3004535, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Structural modifications of abietic acid and a computational protocol to predict their compatibility in different environments.

Structural modifications of abietic acid and a computational protocol to predict their compatibility in different environments.

Journal: RSC advances
Published: May 25, 2026

Targeting endometrial cancer stem cells through aldehyde dehydrogenase-mediated photodynamic therapy based on enhanced ring-fused chlorins.

Targeting endometrial cancer stem cells through aldehyde dehydrogenase-mediated photodynamic therapy based on enhanced ring-fused chlorins.

Journal: European journal of medicinal chemistry
Published: May 14, 2026

trans-A2B-Corroles containing an oxime moiety: Novel photosensitizers for photodynamic therapy of lung cancer.

trans-A2B-Corroles containing an oxime moiety: Novel photosensitizers for photodynamic therapy of lung cancer.

Journal: European journal of medicinal chemistry
Published: May 22, 2025

Correction: Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: the search for selective p53-activating agents for colorectal cancer therapy.

Correction: Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: the search for selective p53-activating agents for colorectal cancer therapy.

Journal: RSC medicinal chemistry
Published: January 20, 2025

3-Tetrazolyl-β-carboline derivatives as potential neuroprotective agents.

3-Tetrazolyl-β-carboline derivatives as potential neuroprotective agents.

Journal: Bioorganic & medicinal chemistry
Published: April 12, 2024

Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: the search for selective p53-activating agents for colorectal cancer therapy.

Chiral hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: the search for selective p53-activating agents for colorectal cancer therapy.

Journal: RSC medicinal chemistry
Published: January 26, 2024

Novel Foscan®-derived ring-fused chlorins for photodynamic therapy of cancer.

Novel Foscan®-derived ring-fused chlorins for photodynamic therapy of cancer.

Journal: Bioorganic & medicinal chemistry
Published: June 20, 2023

Synthesis of novel chiral spiro-β-lactams from nitrile oxides and 6-(Z)-(benzoylmethylene)penicillanate: batch, microwave-induced and continuous flow methodologies.

Synthesis of novel chiral spiro-β-lactams from nitrile oxides and 6-(Z)-(benzoylmethylene)penicillanate: batch, microwave-induced and continuous flow methodologies.

Journal: RSC advances
Published: August 03, 2022

Insights into the anticancer activity of chiral alkylidene-β-lactams and alkylidene-γ-lactams: Synthesis and biological investigation.

Insights into the anticancer activity of chiral alkylidene-β-lactams and alkylidene-γ-lactams: Synthesis and biological investigation.

Journal: Bioorganic & medicinal chemistry
Published: December 27, 2021

Synthesis and structure-activity relationships of new chiral spiro-β-lactams highly active against HIV-1 and Plasmodium.

Synthesis and structure-activity relationships of new chiral spiro-β-lactams highly active against HIV-1 and Plasmodium.

Journal: European journal of medicinal chemistry
Published: March 03, 2021

Reactivity of steroidal 1-azadienes toward enamines: an approach to novel chiral penta- and hexacyclic steroids.

Reactivity of steroidal 1-azadienes toward enamines: an approach to novel chiral penta- and hexacyclic steroids.

Journal: Organic & biomolecular chemistry
Published: January 13, 2021

Novel fluorinated ring-fused chlorins as promising PDT agents against melanoma and esophagus cancer.

Novel fluorinated ring-fused chlorins as promising PDT agents against melanoma and esophagus cancer.

Journal: RSC medicinal chemistry
Published: December 28, 2020
Showing 1-12 of 28

Last Updated: 09/26/2026